Molecular Cancer (Feb 2022)

PBK/TOPK inhibitor OTS964 resistance is mediated by ABCB1-dependent transport function in cancer: in vitro and in vivo study

  • Yuqi Yang,
  • Qiu-Xu Teng,
  • Zhuo-Xun Wu,
  • Jing-Quan Wang,
  • Zi-Ning Lei,
  • Sabrina Lusvarghi,
  • Suresh V. Ambudkar,
  • Ning Ji,
  • Zhe-Sheng Chen

DOI
https://doi.org/10.1186/s12943-022-01512-0
Journal volume & issue
Vol. 21, no. 1
pp. 1 – 6

Abstract

Read online

Highlights ABCB1 overexpression significantly desensitized both drug-selected and gene-transfected cells, which overexpress ABCB1, to OTS964 and that this drug resistance can be antagonized by verapamil, a known ABCB1 inhibitor. Consistently, a similar trend was observed in tumor-bearing mice. OTS964 stimulated ATPase activity of ABCB1 and upregulated expression levels of ABCB1, resulting in induced resistance to other ABCB1 substrate-drugs, such as paclitaxel. OTS964 received a comparable affinity score and can dock into the substrate-binding site of human ABCB1 protein.

Keywords